331 related articles for article (PubMed ID: 15047610)
1. Assessment of the severity of hypoglycemia and glycemic lability in type 1 diabetic subjects undergoing islet transplantation.
Ryan EA; Shandro T; Green K; Paty BW; Senior PA; Bigam D; Shapiro AM; Vantyghem MC
Diabetes; 2004 Apr; 53(4):955-62. PubMed ID: 15047610
[TBL] [Abstract][Full Text] [Related]
2. A patient with severe, recurrent hypoglycemia and glycemic lability who underwent islet transplantation.
Ryan EA; Shapiro AJ
Nat Clin Pract Endocrinol Metab; 2006 Jun; 2(6):349-53; quiz 354. PubMed ID: 16932312
[TBL] [Abstract][Full Text] [Related]
3. Assessment of glycemic lability and severity of hypoglycemia in Korean patients with type 1 diabetes.
Kim SK; Kwon SB; Yoon KH; Ahn KJ; Kang JG; Jung HS; Kang ES; Kim JH; Kim KW
Endocr J; 2011; 58(6):433-40. PubMed ID: 21505268
[TBL] [Abstract][Full Text] [Related]
4. Five-year follow-up after clinical islet transplantation.
Ryan EA; Paty BW; Senior PA; Bigam D; Alfadhli E; Kneteman NM; Lakey JR; Shapiro AM
Diabetes; 2005 Jul; 54(7):2060-9. PubMed ID: 15983207
[TBL] [Abstract][Full Text] [Related]
5. Consistency of quantitative scores of hypoglycemia severity and glycemic lability and comparison with continuous glucose monitoring system measures in long-standing type 1 diabetes.
Senior PA; Bellin MD; Alejandro R; Yankey JW; Clarke WR; Qidwai JC; Schwieger TR; Eggerman TL; Robien MA; Rickels MR;
Diabetes Technol Ther; 2015 Apr; 17(4):235-42. PubMed ID: 25629445
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol.
Ryan EA; Lakey JR; Rajotte RV; Korbutt GS; Kin T; Imes S; Rabinovitch A; Elliott JF; Bigam D; Kneteman NM; Warnock GL; Larsen I; Shapiro AM
Diabetes; 2001 Apr; 50(4):710-9. PubMed ID: 11289033
[TBL] [Abstract][Full Text] [Related]
7. Reduction of blood glucose variability in type 1 diabetic patients treated by pancreatic islet transplantation: interest of continuous glucose monitoring.
Kessler L; Passemard R; Oberholzer J; Benhamou PY; Bucher P; Toso C; Meyer P; Penfornis A; Badet L; Wolf P; Colin C; Morel P; Pinget M;
Diabetes Care; 2002 Dec; 25(12):2256-62. PubMed ID: 12453970
[TBL] [Abstract][Full Text] [Related]
8. Successful islet transplantation: continued insulin reserve provides long-term glycemic control.
Ryan EA; Lakey JR; Paty BW; Imes S; Korbutt GS; Kneteman NM; Bigam D; Rajotte RV; Shapiro AM
Diabetes; 2002 Jul; 51(7):2148-57. PubMed ID: 12086945
[TBL] [Abstract][Full Text] [Related]
9. Secretory unit of islet transplant objects (SUITO) index can predict severity of hypoglycemic episodes in clinical islet cell transplantation.
Takita M; Matsumoto S; Qin H; Noguchi H; Shimoda M; Chujo D; Itoh T; Sugimoto K; Onaca N; Naziruddin B; Levy MF
Cell Transplant; 2012; 21(1):91-8. PubMed ID: 21669043
[TBL] [Abstract][Full Text] [Related]
10. Assessment of glycemic control after islet transplantation using the continuous glucose monitor in insulin-independent versus insulin-requiring type 1 diabetes subjects.
Paty BW; Senior PA; Lakey JR; Shapiro AM; Ryan EA
Diabetes Technol Ther; 2006 Apr; 8(2):165-73. PubMed ID: 16734547
[TBL] [Abstract][Full Text] [Related]
11. Glycemic thresholds for activation of counterregulatory hormone and symptom responses in islet transplant recipients.
Rickels MR; Schutta MH; Mueller R; Kapoor S; Markmann JF; Naji A; Teff KL
J Clin Endocrinol Metab; 2007 Mar; 92(3):873-9. PubMed ID: 17192287
[TBL] [Abstract][Full Text] [Related]
12. Intrahepatic islet transplantation in type 1 diabetic patients does not restore hypoglycemic hormonal counterregulation or symptom recognition after insulin independence.
Paty BW; Ryan EA; Shapiro AM; Lakey JR; Robertson RP
Diabetes; 2002 Dec; 51(12):3428-34. PubMed ID: 12453896
[TBL] [Abstract][Full Text] [Related]
13. Continuous glucose monitoring after islet transplantation in type 1 diabetes: an excellent graft function (β-score greater than 7) Is required to abrogate hyperglycemia, whereas a minimal function is necessary to suppress severe hypoglycemia (β-score greater than 3).
Vantyghem MC; Raverdy V; Balavoine AS; Defrance F; Caiazzo R; Arnalsteen L; Gmyr V; Hazzan M; Noël C; Kerr-Conte J; Pattou F
J Clin Endocrinol Metab; 2012 Nov; 97(11):E2078-83. PubMed ID: 22996144
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment of brittle diabetes following total pancreatectomy by islet allotransplantation: a case report.
Koh A; Imes S; Shapiro AM; Senior PA
JOP; 2013 Jul; 14(4):428-31. PubMed ID: 23846941
[TBL] [Abstract][Full Text] [Related]
15. Ten-Year Outcome of Islet Alone or Islet After Kidney Transplantation in Type 1 Diabetes: A Prospective Parallel-Arm Cohort Study.
Vantyghem MC; Chetboun M; Gmyr V; Jannin A; Espiard S; Le Mapihan K; Raverdy V; Delalleau N; Machuron F; Hubert T; Frimat M; Van Belle E; Hazzan M; Pigny P; Noel C; Caiazzo R; Kerr-Conte J; Pattou F;
Diabetes Care; 2019 Nov; 42(11):2042-2049. PubMed ID: 31615852
[TBL] [Abstract][Full Text] [Related]
16. Indications for clinical islet transplantation today and in the forseeable future--the diabetologist's point of view.
Federlin K; Pozza G
J Mol Med (Berl); 1999 Jan; 77(1):148-52. PubMed ID: 9930951
[TBL] [Abstract][Full Text] [Related]
17. Pancreas islet transplantation in patients with type 1 diabetes mellitus after kidney transplantation.
Gonzalez Molina M; Alonso A; Briones R; Fernandez N; Caballero A; Miranda JM; Navarro A; Castro MJ; Burgos D; Cabello M; Sola E; Escaño A; Muñoz J
Transplant Proc; 2005 Apr; 37(3):1443-5. PubMed ID: 15866632
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a new measure of blood glucose variability in diabetes.
Kovatchev BP; Otto E; Cox D; Gonder-Frederick L; Clarke W
Diabetes Care; 2006 Nov; 29(11):2433-8. PubMed ID: 17065680
[TBL] [Abstract][Full Text] [Related]
19. Long-Term Improvement in Glucose Control and Counterregulation by Islet Transplantation for Type 1 Diabetes.
Rickels MR; Peleckis AJ; Markmann E; Dalton-Bakes C; Kong SM; Teff KL; Naji A
J Clin Endocrinol Metab; 2016 Nov; 101(11):4421-4430. PubMed ID: 27571180
[TBL] [Abstract][Full Text] [Related]
20. Improved Health-Related Quality of Life in a Phase 3 Islet Transplantation Trial in Type 1 Diabetes Complicated by Severe Hypoglycemia.
Foster ED; Bridges ND; Feurer ID; Eggerman TL; Hunsicker LG; Alejandro R;
Diabetes Care; 2018 May; 41(5):1001-1008. PubMed ID: 29563196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
